Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|October 16, 2018
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced ObesityDaniela Gentile, Matteo Fornai, Carolina Pellegrini, et al.
Journal of Drug Targeting|June 12, 2024
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitisClelia Di Salvo, Vanessa D'Antongiovanni, Laura Benvenuti, et al.
Inflammation|March 26, 2022
Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of ColitisVanessa D'Antongiovanni, Carolina Pellegrini, Laura Benvenuti, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2020
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximabLorenzo Bertani, Matteo Fornai, Marco Fornili, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 23, 2020
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric gliaLuca Antonioli, Vanessa D'Antongiovanni, Carolina Pellegrini, et al.
Frontiers in Pharmacology|December 18, 2018
Pathophysiology of NSAID-Associated Intestinal Lesions in the Rat: Luminal Bacteria and Mucosal Inflammation as Targets for PreventionRocchina Colucci, Carolina Pellegrini, Matteo Fornai, et al.
Pageof 4